Eupraxia Pharmaceuticals Inc.

TSX:EPRX Stock Report

Market Cap: CA$157.8m

Eupraxia Pharmaceuticals Management

Management criteria checks 3/4

Eupraxia Pharmaceuticals' CEO is James Helliwell, appointed in Jul 2012, has a tenure of 12.33 years. total yearly compensation is $517.30K, comprised of 70.2% salary and 29.8% bonuses, including company stock and options. directly owns 1.89% of the company’s shares, worth CA$2.99M. The average tenure of the management team and the board of directors is 2.8 years and 11.8 years respectively.

Key information

James Helliwell

Chief executive officer

US$517.3k

Total compensation

CEO salary percentage70.2%
CEO tenure12.3yrs
CEO ownership1.9%
Management average tenure2.8yrs
Board average tenure11.8yrs

Recent management updates

Recent updates

Health Check: How Prudently Does Eupraxia Pharmaceuticals (TSE:EPRX) Use Debt?

Jul 30
Health Check: How Prudently Does Eupraxia Pharmaceuticals (TSE:EPRX) Use Debt?

CEO Compensation Analysis

How has James Helliwell's remuneration changed compared to Eupraxia Pharmaceuticals's earnings?
DateTotal CompensationSalaryCompany Earnings
Jun 30 2024n/an/a

-US$27m

Mar 31 2024n/an/a

-US$30m

Dec 31 2023US$517kUS$363k

-US$28m

Sep 30 2023n/an/a

-US$25m

Jun 30 2023n/an/a

-US$24m

Mar 31 2023n/an/a

-US$20m

Dec 31 2022US$953kUS$325k

-US$18m

Sep 30 2022n/an/a

-US$14m

Jun 30 2022n/an/a

-US$14m

Mar 31 2022n/an/a

-US$14m

Dec 31 2021US$1mUS$297k

-US$19m

Compensation vs Market: James's total compensation ($USD517.30K) is above average for companies of similar size in the Canadian market ($USD173.45K).

Compensation vs Earnings: James's compensation has been consistent with company performance over the past year.


CEO

James Helliwell (50 yo)

12.3yrs

Tenure

US$517,299

Compensation

Dr. James A. Helliwell, M.D., FRCPC serves as the Chief Executive Officer since July 2012 at Eupraxia Pharmaceuticals Inc. and served as its President until May 3, 2021. Dr. Helliwell serves as a Clinical...


Leadership Team

NamePositionTenureCompensationOwnership
James Helliwell
CEO & Director12.3yrsUS$517.30k1.89%
CA$ 3.0m
Bruce Cousins
President & CFO3.5yrsUS$368.72k0.32%
CA$ 506.3k
Amanda Malone
Chief Scientific Officer & COO12.2yrsUS$368.72k0.13%
CA$ 205.3k
Paul Brennan
Chief Business Officer2yrsUS$343.12k0.076%
CA$ 120.5k
Mark Kowalski
Chief Medical Officer1.5yrsUS$1.15m0.022%
CA$ 35.4k
Rahul Sarugaser
Executive Vice President of Corporate Developmentless than a yearno datano data

2.8yrs

Average Tenure

56.5yo

Average Age

Experienced Management: EPRX's management team is considered experienced (2.8 years average tenure).


Board Members

NamePositionTenureCompensationOwnership
James Helliwell
CEO & Director12.3yrsUS$517.30k1.89%
CA$ 3.0m
Simon Pimstone
Independent Chairman11.8yrsUS$42.23k0.024%
CA$ 38.2k
Richard Glickman
Independent Director3.7yrsUS$29.86k0.039%
CA$ 61.7k
Paul Geyer
Independent Director11.8yrsUS$23.56k0.96%
CA$ 1.5m
John Montalbano
Independent Director11.8yrsUS$29.86k3.4%
CA$ 5.4m
Michael Wilmink
Independent Director11.8yrsUS$23.56k0.63%
CA$ 996.1k

11.8yrs

Average Tenure

58yo

Average Age

Experienced Board: EPRX's board of directors are seasoned and experienced ( 11.8 years average tenure).